We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On November 25, 2008, the Competition Bureau released its second report, Benefiting from Generic Drug Competition in Canada: The Way Forward, on the competitive framework for generic drugs in Canada
